Results 111 to 120 of about 1,587 (161)

Comparison of the efficacy of nifedipine with ritodrine, nitroglycerine and magnesium sulfate for the management of preterm labor: a systematic review and meta-analysis. [PDF]

BMC Pregnancy Childbirth
Zamani M, Alimi R, Arabi SM, Moradi M, Azmoude E.   +4 more
europepmc   +1 more source

Anesthesia for fetal interventions: Caring for mother and fetus prior to birth. [PDF]

J Anesth Transl Med
Nelson O, Lin EE.
europepmc   +1 more source

Optimal management strategies for promoting gestational extension in dichorionic diamniotic twin pregnancies. [PDF]

Front Physiol
Chen C, Fan C, Wang B, Zhu P.
europepmc   +1 more source

Diagnostic Efficacy of Cervical Elastography in Predicting Spontaneous Preterm Birth in Pregnancies with Threatened Preterm Labor. [PDF]

Diagnostics (Basel)
Kwon H, Sung JH, Park HS, Kwon JY, Jung YJ, Seol HJ, Kim HM, Seong WJ, Hwang HS, Oh SY, On Behalf Of The Korean Consortium For The Study Of Cervical Elastography In Prediction Of Preterm Delivery.   +10 more
europepmc   +1 more source

KV7 channel activation inhibits human and murine myometrium contractility and delays delivery in a mouse model of preterm birth

Tribe R, Mansour Y, Mistry H, Chin-Smith E, Zaleska M, Sekulich D, Herington J, Reese J, Patel R, Aaronson P, Slater D, England S, Greenwood I, Johnson M, Taylor P.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Prostaglandin inhibitors as tocolytic agents

Seminars in Perinatology, 2001
Indomethacin, a nonspecific prostaglandin synthetase inhibitor, gained popularity several decades ago as a potent tocolytic agent. This popularity, however, was tempered by concerns over fetal and neonatal complications associated with its use. However, with better recognition of the safety limitations, there has been a renewed interest in using ...
S T Vermillion
exaly   +3 more sources

Fetal and neonatal effects of indomethacin used as a tocolytic agent

American Journal of Obstetrics and Gynecology, 1985
beta-Mimetic agents are currently recommended for tocolysis. Serious adverse reactions including maternal death may complicate their use. Prostaglandin synthetase inhibitors are effective tocolytic agents. Reports of potential adverse effects have limited clinical use in North America.
D K, Dudley, M J, Hardie
exaly   +7 more sources

Effect of tocolytic agents on fetal umbilical velocimetry

American Journal of Obstetrics and Gynecology, 1990
In this prospective study, we sought to examine the changes in umbilical vascular resistance induced by tocolytic therapy. Umbilical artery velocimetry was performed in 46 patients with preterm labor before tocolysis and at 1 hour and 24 hours after tocolysis was initiated.
R M Patterson
exaly   +3 more sources

The Safety and Efficacy of Tocolytic Agents for the Treatment of Preterm Labor

Obstetrical and Gynecological Survey, 1990
Pharmacologic inhibition of uterine contractions remains the mainstay of treatment for preterm labor despite the ongoing controversy regarding its effectiveness. A diverse variety of tocolytic medications have been proposed for clinical use, with betamimetics and magnesium sulfate being the common therapeutic agents of choice in the United States today.
R E, Besinger, J R, Niebyl
exaly   +3 more sources

A Comparison of the Relative Toxicities of β-Sympathomimetic Tocolytic Agents

American Journal of Perinatology, 1985
To define the relative toxicities of ritodrine sulfate, terbutaline sulfate, hexaprenaline sulfate, and ritodrine with betamethasone mongrel dogs were treated with these agents for 19 hours. The maximum dose of ritodrine was 900 microgram/min (N = 5), terbutaline 120 micrograms/min (N = 4) and hexaprenaline 1.5 micrograms/min (N = 4). Betamethasone was
Gary Hankins, John C Hauth, G D Hankins
exaly   +3 more sources